Trump announces reforms to accelerate access to psychedelic drug treatments

Source: US news | The Guardian · Bias: Center Left

Summary

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaineDonald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs.The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat post-traumatic stress disorder. Continue reading...

Related Coverage

Daily Analysis

Read the full Parallax Pulse for April 18, 2026 — an AI-powered analysis of how Left and Right media covered the biggest stories this day.

More Headlines From April 18, 2026

Trump announces reforms to accelerate access to psychedelic drug treatments
US news | The Guardian

Trump announces reforms to accelerate access to psychedelic drug treatments

Center Left

President signed executive order directing FDA to expedite review of psychedelic drugs including ibogaineDonald Trump on Saturday announced reforms intended to speed up access to medical research and treatment based on psychedelic drugs.The president signed an executive order directing the federal Food and Drug Administration (FDA) to expedite review of drugs such as ibogaine, a drug that US military veteran groups have said can help treat post-traumatic stress disorder. Continue reading...

Trump announces reforms to accelerate access to psychedelic drug treatments | ParallaxNews.io